http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
천갑진,김영돈 대한간학회 2015 간학회 싱글토픽 심포지움 Vol.2015 No.2
Nonalcoholic fatty liver disease (NAFLD) is an increasingly common cause of chronic liver disease in Korea and it is associated with increased liver-related mortality and hepatocellular carcinoma. But the natural history of NAFLD remains unclear. The prognosis of NAFLD depends on the histological subtype. The more than 60% patients had disease remission or remained the same. The weight reduction was a predictor. Diet and lifestyle modification remain the mainstay of treatment. At present there are no approved therapies. For patients with NASH(Nonalcoholic steatohepatitis) and advanced fibrosis, current liver-directed pharmacotherapy with vitamin E and pioglitazone offer some benefits in selected cases. However, the beneficial effects of these therapies must be balanced with the potential adverse effects, limiting their widespread use. Coexisting comorbidity must be diagnosed and treated because cardiovascular disease remains primary cause of death in these patients. The new agents currently in trial provide the first hope of effective, targeted pharmacotherapy in this field.